Potential influence of the corpus luteum on circulating reproductive and volume regulatory hormones, angiogenic and immunoregulatory factors in pregnant women

• Published in: American journal of physiology: endocrinology and metabolism Vol. 317; no. 4; pp. E677 - E685
• Main Authors: Conrad, Kirk P, Graham, Georgia M, Chi, Yueh-Yun, Zhai, Xiaoman, Li, Minjie, Williams, R Stan, Rhoton-Vlasak, Alice, Segal, Mark S, Wood, Charles E, Keller-Wood, Maureen
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.10.2019
• Series: Translational Physiology
• Subjects: Adult; C-Reactive Protein - analysis; Cohort Studies; Corpus Luteum - metabolism; Corpus Luteum - physiology; Female; Fertilization in Vitro; Gonadal Steroid Hormones - metabolism; Humans; Hypothalamo-Hypophyseal System - drug effects; Immune System - physiology; Infant, Newborn; Intercellular Signaling Peptides and Proteins - blood; Middle Aged; Neovascularization, Physiologic - physiology; Ovulation Induction; Pregnancy; Pregnancy Outcome; in vitro fertilization; relaxin; frozen embryo transfer; sFLT-1; ovarian stimulation
• ISSN: 0193-1849; 1522-1555
• DOI: 10.1152/ajpendo.00225.2019

Cardiovascular function is impaired and preeclampsia risk elevated in women conceiving by in vitro fertilization (IVF) in the absence of a corpus luteum (CL). Here, we report the serial evaluation of hormones and other circulating factors in women who conceived with (or without) IVF. After a prepregnancy baseline, the study participants ( = 19-24/cohort) were evaluated six times during pregnancy and once postpartum (~1.6 yr). IVF pregnancies were stratified by protocol and CL number, i.e., ovarian stimulation (>1 CL) or hypothalamic-pituitary suppression (0 CL) versus spontaneous conceptions (1 CL). Results include the following: ) relaxin was undetectable throughout pregnancy (including late gestation) in the 0 CL cohort, but markedly elevated in ~50% of women in the >1 CL cohort; ) progesterone, plasma renin activity, and aldosterone transiently surged at 5-6 gestational weeks in the >1 CL group; ) soluble vascular endothelial growth factor-1 (sFLT-1) abruptly increased between 5-6 and 7-9 gestational weeks in all three participant cohorts, producing a marked elevation in sFLT-1/PLGF (placental growth factor) ratio exceeding any other time point during pregnancy; ) sFLT-1 was higher throughout most of gestation in both IVF cohorts with or without abnormal obstetrical outcomes; ) during pregnancy, C-reactive protein (CRP) increased in 0 and 1 CL, but not >1 CL cohorts; and ) plasma protein, but not hemoglobin, was lower in the >1 CL group throughout gestation. The findings highlight that, compared with spontaneously conceived pregnancy, the maternal milieu of IVF pregnancy is not physiologic, and the specific perturbations vary according to IVF protocol and CL status.